MedSource   Report issue

For profit Phase 2 Phase 3
Founded: Houston TX United States (1997)
Status: Acquired by Ergomed (2020)

Organization Overview

First Clinical Trial
2004
NCT00565123
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

MedSource Polska

Active Ingredients

Drugs in Phase 3 Trials (1)

levofloxacin (levaquin) (1 trial)

Drugs in Phase 2 Trials (2)

docetaxel (taxotere) (1 trial)

trovafloxacin (trovan) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Conjunctivitis (Phase 3)

Conjunctivitis, Bacterial (Phase 3)

Prostatic Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 3